Bespak in the news
Inhaled drug delivery devices
Tamtam found 17 recent articles about Bespak.
- Bespak Europe Number of Employees 2026 | Employee Count & Headcount Data
Bespak Europe Ltd. is projected to grow its workforce to 688 employees by March 2026, marking a 38.2% increase from 2023.
- 100 home-scheme refused because of impact on Jodrell Bank and nearby business
A 101-home development was rejected due to its negative impact on Jodrell Bank and Bespak's expansion plans.
- 13/04/2026 - Council celebrates world first green inhaler manufacturer during 'Made in Cheshire' visit
Bespak is manufacturing the world's first low carbon inhaler in Holmes Chapel, supporting green pharmaceutical innovation and local job growth.
- Bespak visit
Bespak launched the first low-carbon inhaler and is expanding into nasal drug delivery from its Holmes Chapel facility.
- Pharmaceutical firm making inhalers leads new Made in Cheshire East business drive
Bespak has been named the lead company for the Made in Cheshire East campaign to highlight regional innovation in sustainable inhaler manufacturing.
- Chiesi and Bespak expand partnership to boost Carbon Minimal Inhaler production with UK manufacturing site
Chiesi and Bespak are scaling up UK manufacturing of low-carbon inhalers for asthma and COPD to meet sustainability and supply chain goals.
- Chiesi and Bespak further collaboration to advance UK production of low carbon inhalers
Chiesi and Bespak are scaling up production of low-carbon inhalers at the Holmes Chapel facility to meet sustainability goals.
- Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site
Chiesi is expanding its partnership with Bespak to increase manufacturing capacity for low-carbon inhalers at the Holmes Chapel site in the UK.
- Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site (1)
Chiesi and Bespak are collaborating on sustainable inhaler production in the UK while the industry platform PharmiWeb closes down.
- Bespak Expands Manufacturing Capacity to Support Chiesi CMI Program
Bespak is expanding its UK manufacturing site to produce sustainable carbon-minimal inhalers for Chiesi Group.
- Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site
Chiesi is expanding its manufacturing partnership with Bespak to produce low-carbon inhalers at scale at the Holmes Chapel facility.
- Sustainability in inhalation: From global agreement to industry action
Bespak is leading the pharmaceutical industry's transition to sustainable inhalation therapy by investing in manufacturing capacity and valves for low-carbon propellants.
- Bespak: Advancing sustainable solutions to helping people breathe
A UK-based CDMO specializing in the development and high-volume manufacture of inhaled drug delivery devices and pharmaceutical products.
- Green light for expansion plan at pharmaceutical firm which will create 150 new jobs
Bespak is expanding its Holmes Chapel facility with a 7,091sqm extension to manufacture low-carbon respiratory medicines and create 150 jobs.
- Approval for Bespak’s 76,000 sq ft expansion, 54 Breck homes
Bespak has received planning approval for a 76,000 sq ft headquarters expansion in Holmes Chapel to increase production capacity and create 150 jobs.
- Pharmaceutical plant expansion set for approval in move that could create 150 jobs
Bespak's manufacturing facility expansion for eco-friendly inhalers is set for approval, creating 150 jobs.
- Setting up the transition to low carbon inhalers with Bespak
Bespak is transitioning to low-carbon inhaler manufacturing to reduce the environmental impact of respiratory medicine propellants.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Bespak?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies